JACC Case Rep. 2024 Jun 8;29(14):102387. doi: 10.1016/j.jaccas.2024.102387. eCollection 2024 Jul 17.
ABSTRACT
We introduce the innovative use of technetium-99m-labeled macroaggregated albumin to diagnose high-output heart failure in a patient with multiple myeloma with persistent congestion symptoms. Symptom resolution occurred with lenalidomide and steroids. This marks the first clinical use of technetium-99m-labeled macroaggregated albumin for clarifying high-output heart failure etiology.
PMID:38912004 | PMC:PMC11193010 | DOI:10.1016/j.jaccas.2024.102387